Elite Pharmaceuticals (ELTP) Current Assets (2011 - 2026)
Elite Pharmaceuticals (ELTP) reported Current Assets of $114.49 million for fiscal Q1 2027 (quarter ended Jun 30, 2026), up 47.0% from $77.86 million a year earlier and up 2.1% from the prior quarter.
Elite Pharmaceuticals (ELTP) Current Assets (2011 - 2026) Analysis & Trends
At the end of FY2026 (ended Mar 31, 2026), Elite Pharmaceuticals posted Current Assets of $112.11 million, up 94.2% from FY2025.
- Current Assets has increased for seven consecutive fiscal years, with a five-year compound annual growth rate of 55.8% (FY2021 to FY2026).
- By fiscal year, Current Assets came in at $57.74 million in FY2025 (+44.3%), $40.01 million in FY2024 (+86.0%), $21.51 million in FY2023 (+14.0%) and $18.86 million in FY2022 (+54.7%).
- The fiscal Q1 2027 figure ranks as the highest quarterly Current Assets in data going back to fiscal Q4 2011.
- Year over year, Current Assets has now increased in each of the last 12 quarters, with growth averaging 64.6% over the last eight quarters.
- Across the past five years, year-over-year growth in Current Assets ran from 12.0% in fiscal Q3 2024 to 101.4% in fiscal Q3 2026.
- Per Business Quant data, the three fiscal quarters before Q1 2027 came in at $112.11 million (Q4 2026), $96.79 million (Q3 2026) and $85.79 million (Q2 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 64.67 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 59.77 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 33.67 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 36.68 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 27.35 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 27.97 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 34.96 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 13.95 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 41.36 Bn |
| 10 | Elite Pharmaceuticals | 258.43 Mn | 140.10 Mn | 13.51 Mn | 114.49 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 114.49 Mn |
| Mar 31, 2026 | 112.11 Mn |
| Dec 31, 2025 | 96.79 Mn |
| Sep 30, 2025 | 85.79 Mn |
| Jun 30, 2025 | 77.86 Mn |
| Mar 31, 2025 | 57.74 Mn |
| Dec 31, 2024 | 48.05 Mn |
| Sep 30, 2024 | 45.29 Mn |
| Jun 30, 2024 | 43.16 Mn |
| Mar 31, 2024 | 40.01 Mn |
| Dec 31, 2023 | 37.16 Mn |
| Sep 30, 2023 | 34.73 Mn |
| Jun 30, 2023 | 27.44 Mn |
| Mar 31, 2023 | 21.51 Mn |
| Dec 31, 2022 | 33.16 Mn |
| Sep 30, 2022 | 30.47 Mn |
| Mar 31, 2022 | 18.86 Mn |
| Dec 31, 2021 | 17.48 Mn |
| Sep 30, 2021 | 15.88 Mn |
| Jun 30, 2021 | 15.32 Mn |
Elite Pharmaceuticals Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=ELTP&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "ELTP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=ELTP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();